{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,11]],"date-time":"2026-11-11T05:03:54Z","timestamp":1794373434734,"version":"4.9.0"},"reference-count":117,"publisher":"American Medical Association (AMA)","issue":"1","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["JAMA"],"published-print":{"date-parts":[[2018,7,3]]},"DOI":"10.1001\/jama.2018.7596","type":"journal-article","created":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T15:32:09Z","timestamp":1530631929000},"page":"72","source":"Crossref","is-referenced-by-count":341,"title":["Management Considerations in Infective Endocarditis"],"prefix":"10.1001","volume":"320","author":[{"given":"Andrew","family":"Wang","sequence":"first","affiliation":[{"name":"Division of Cardiology, Department of Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jeffrey G.","family":"Gaca","sequence":"additional","affiliation":[{"name":"Division of Cardiovascular and Thoracic Surgery, Department of Surgery, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vivian H.","family":"Chu","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Medicine, Duke University Medical Center, Durham, North Carolina"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10","reference":[{"issue":"5","key":"jrv180005r1","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1001\/archinternmed.2008.603","article-title":"Clinical presentation, etiology, and outcome of infective endocarditis in the 21st century: the International Collaboration on Endocarditis-Prospective Cohort Study.","volume":"169","author":"Murdoch","year":"2009","journal-title":"Arch Intern Med"},{"issue":"9","key":"jrv180005r2","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1093\/cid\/cis199","article-title":"Preeminence of Staphylococcus aureus in infective endocarditis: a 1-year population-based survey.","volume":"54","author":"Selton-Suty","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"9","key":"jrv180005r3","doi-asserted-by":"publisher","first-page":"586","DOI":"10.7326\/0003-4819-150-9-200905050-00004","article-title":"Health care-associated native valve endocarditis: importance of non-nosocomial acquisition.","volume":"150","author":"Benito","year":"2009","journal-title":"Ann Intern Med"},{"issue":"10","key":"jrv180005r4","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.14219\/jada.archive.2009.0046","article-title":"Poor oral hygiene as a risk factor for infective endocarditis-related bacteremia.","volume":"140","author":"Lockhart","year":"2009","journal-title":"J Am Dent Assoc"},{"issue":"19","key":"jrv180005r5","doi-asserted-by":"publisher","first-page":"2095","DOI":"10.1001\/archinte.168.19.2095","article-title":"Current features of infective endocarditis in elderly patients: results of the International Collaboration on Endocarditis Prospective Cohort Study.","volume":"168","author":"Durante-Mangoni","year":"2008","journal-title":"Arch Intern Med"},{"issue":"10","key":"jrv180005r6","doi-asserted-by":"publisher","first-page":"1165","DOI":"10.4065\/82.10.1165","article-title":"Risk factors for infective endocarditis and outcome of patients with Staphylococcus aureus bacteremia.","volume":"82","author":"Hill","year":"2007","journal-title":"Mayo Clin Proc"},{"issue":"4","key":"jrv180005r7","doi-asserted-by":"publisher","first-page":"681","DOI":"10.1016\/0002-9343(87)90001-5","article-title":"Underlying cardiac lesions in adults with infective endocarditis: the changing spectrum.","volume":"82","author":"McKinsey","year":"1987","journal-title":"Am J Med"},{"issue":"23","key":"jrv180005r8","doi-asserted-by":"publisher","first-page":"2842","DOI":"10.1161\/01.CIR.102.23.2842","article-title":"Risk factors for infective endocarditis: oral hygiene and nondental exposures.","volume":"102","author":"Strom","year":"2000","journal-title":"Circulation"},{"issue":"4","key":"jrv180005r9","doi-asserted-by":"publisher","first-page":"429","DOI":"10.1016\/j.cjca.2012.04.018","article-title":"Dental scaling and risk reduction in infective endocarditis: a nationwide population-based case-control study.","volume":"29","author":"Chen","year":"2013","journal-title":"Can J Cardiol"},{"issue":"19","key":"jrv180005r10","doi-asserted-by":"publisher","first-page":"2070","DOI":"10.1016\/j.jacc.2015.03.518","article-title":"Trends in infective endocarditis incidence, microbiology, and valve replacement in the United States from 2000 to 2011.","volume":"65","author":"Pant","year":"2015","journal-title":"J Am Coll Cardiol"},{"issue":"4","key":"jrv180005r11","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1086\/313753","article-title":"Proposed modifications to the Duke criteria for the diagnosis of infective endocarditis.","volume":"30","author":"Li","year":"2000","journal-title":"Clin Infect Dis"},{"issue":"10","key":"jrv180005r12","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1086\/595712","article-title":"Contemporary epidemiology and prognosis of health care\u2013associated infective endocarditis.","volume":"47","author":"Fernandez-Hidalgo","year":"2008","journal-title":"Clin Infect Dis"},{"issue":"16","key":"jrv180005r13","doi-asserted-by":"publisher","first-page":"1652","DOI":"10.1001\/jama.2017.4287","article-title":"Trends in infective endocarditis in California and New York State, 1998-2013.","volume":"317","author":"Toyoda","year":"2017","journal-title":"JAMA"},{"issue":"3","key":"jrv180005r14","doi-asserted-by":"publisher","first-page":"e60033","DOI":"10.1371\/journal.pone.0060033","article-title":"Infective endocarditis in the US, 1998-2009: a nationwide study.","volume":"8","author":"Bor","year":"2013","journal-title":"PLoS One"},{"issue":"2","key":"jrv180005r15","doi-asserted-by":"publisher","first-page":"151","DOI":"10.1016\/j.jacc.2015.10.065","article-title":"Systematic search for present and potential portals of entry for infective endocarditis.","volume":"67","author":"Delahaye","year":"2016","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"jrv180005r16","doi-asserted-by":"publisher","first-page":"ofw157","DOI":"10.1093\/ofid\/ofw157","article-title":"Increasing infectious endocarditis admissions among young people who inject drugs.","volume":"3","author":"Wurcel","year":"2016","journal-title":"Open Forum Infect Dis"},{"issue":"294","key":"jrv180005r17","first-page":"1","article-title":"Drug overdose deaths in the United States, 1999-2016.","author":"Hedegaard","year":"2017","journal-title":"NCHS Data Brief"},{"issue":"6","key":"jrv180005r18","doi-asserted-by":"publisher","first-page":"603","DOI":"10.1016\/j.amjms.2016.08.010","article-title":"Opiate Injection-associated infective endocarditis in the Southeastern United States.","volume":"352","author":"Hartman","year":"2016","journal-title":"Am J Med Sci"},{"issue":"22","key":"jrv180005r19","doi-asserted-by":"publisher","first-page":"569","DOI":"10.15585\/mmwr.mm6622a1","article-title":"Hospitalizations for endocarditis and associated health care costs among persons with diagnosed drug dependence\u2014North Carolina, 2010-2015.","volume":"66","author":"Fleischauer","year":"2017","journal-title":"MMWR Morb Mortal Wkly Rep"},{"issue":"10","key":"jrv180005r20","doi-asserted-by":"publisher","first-page":"1001","DOI":"10.1016\/j.jacc.2011.04.033","article-title":"16-Year trends in the infection burden for pacemakers and implantable cardioverter-defibrillators in the United States 1993 to 2008.","volume":"58","author":"Greenspon","year":"2011","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"jrv180005r21","doi-asserted-by":"publisher","first-page":"767","DOI":"10.1093\/europace\/euv053","article-title":"Risk factors for cardiac implantable electronic device infection: a systematic review and meta-analysis.","volume":"17","author":"Polyzos","year":"2015","journal-title":"Europace"},{"issue":"16","key":"jrv180005r22","doi-asserted-by":"publisher","first-page":"1727","DOI":"10.1001\/jama.2012.497","article-title":"Clinical characteristics and outcome of infective endocarditis involving implantable cardiac devices.","volume":"307","author":"Athan","year":"2012","journal-title":"JAMA"},{"issue":"8","key":"jrv180005r23","doi-asserted-by":"publisher","first-page":"2098","DOI":"10.1161\/01.CIR.95.8.2098","article-title":"Systemic infection related to endocarditis on pacemaker leads: clinical presentation and management.","volume":"95","author":"Klug","year":"1997","journal-title":"Circulation"},{"issue":"25","key":"jrv180005r24","doi-asserted-by":"publisher","first-page":"e1159","DOI":"10.1161\/CIR.0000000000000503","article-title":"2017 AHA\/ACC Focused Update of the 2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Clinical Practice Guidelines.","volume":"135","author":"Nishimura","year":"2017","journal-title":"Circulation"},{"issue":"3","key":"jrv180005r25","doi-asserted-by":"publisher","first-page":"200","DOI":"10.1016\/0002-9343(94)90143-0","article-title":"New criteria for diagnosis of infective endocarditis: utilization of specific echocardiographic findings. Duke Endocarditis Service.","volume":"96","author":"Durack","year":"1994","journal-title":"Am J Med"},{"issue":"2","key":"jrv180005r26","doi-asserted-by":"publisher","first-page":"363","DOI":"10.1016\/S0891-5520(02)00002-8","article-title":"Diagnostic methods current best practices and guidelines for isolation of bacteria and fungi in infective endocarditis.","volume":"16","author":"Towns","year":"2002","journal-title":"Infect Dis Clin North Am"},{"issue":"24","key":"jrv180005r27","doi-asserted-by":"publisher","first-page":"3012","DOI":"10.1001\/jama.293.24.3012","article-title":"Staphylococcus aureus endocarditis: a consequence of medical progress.","volume":"293","author":"Fowler","year":"2005","journal-title":"JAMA"},{"issue":"12","key":"jrv180005r28","doi-asserted-by":"publisher","first-page":"6213","DOI":"10.1128\/AAC.01563-13","article-title":"High-dose daptomycin therapy for left-sided infective endocarditis: a prospective study from the international collaboration on endocarditis.","volume":"57","author":"Carugati","year":"2013","journal-title":"Antimicrob Agents Chemother"},{"issue":"9","key":"jrv180005r29","doi-asserted-by":"publisher","first-page":"1355","DOI":"10.1086\/599181","article-title":"Heterogeneous vancomycin-intermediate susceptibility phenotype in bloodstream methicillin-resistant Staphylococcus aureus isolates from an international cohort of patients with infective endocarditis: prevalence, genotype, and clinical significance.","volume":"200","author":"Bae","year":"2009","journal-title":"J Infect Dis"},{"issue":"6","key":"jrv180005r30","doi-asserted-by":"publisher","first-page":"1086","DOI":"10.1016\/j.ahj.2007.07.023","article-title":"The relationship between the initiation of antimicrobial therapy and the incidence of stroke in infective endocarditis: an analysis from the ICE Prospective Cohort Study (ICE-PCS).","volume":"154","author":"Dickerman","year":"2007","journal-title":"Am Heart J"},{"key":"jrv180005r31","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1186\/1471-2334-14-230","article-title":"Predicting the occurrence of embolic events: an analysis of 1456 episodes of infective endocarditis from the Italian Study on Endocarditis (SEI).","volume":"14","author":"Rizzi","year":"2014","journal-title":"BMC Infect Dis"},{"issue":"1","key":"jrv180005r32","doi-asserted-by":"publisher","first-page":"69","DOI":"10.1161\/CIRCULATIONAHA.104.493155","article-title":"Risk of embolism and death in infective endocarditis: prognostic value of echocardiography: a prospective multicenter study.","volume":"112","author":"Thuny","year":"2005","journal-title":"Circulation"},{"issue":"7","key":"jrv180005r33","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1136\/hrt.2008.152975","article-title":"Coagulase-negative staphylococcal prosthetic valve endocarditis\u2014a contemporary update based on the International Collaboration on Endocarditis.","volume":"95","author":"Chu","year":"2009","journal-title":"Heart"},{"issue":"5","key":"jrv180005r34","doi-asserted-by":"publisher","first-page":"e63181","DOI":"10.1371\/journal.pone.0063181","article-title":"HACEK infective endocarditis: characteristics and outcomes from a large, multi-national cohort.","volume":"8","author":"Chambers","year":"2013","journal-title":"PLoS One"},{"issue":"11","key":"jrv180005r35","doi-asserted-by":"publisher","first-page":"1677","DOI":"10.1086\/497595","article-title":"Prolonged incubation and extensive subculturing do not increase recovery of clinically significant microorganisms from standard automated blood cultures.","volume":"41","author":"Baron","year":"2005","journal-title":"Clin Infect Dis"},{"issue":"1","key":"jrv180005r36","doi-asserted-by":"publisher","first-page":"50","DOI":"10.1086\/317550","article-title":"Fungal endocarditis: evidence in the world literature, 1965-1995.","volume":"32","author":"Ellis","year":"2001","journal-title":"Clin Infect Dis"},{"issue":"1","key":"jrv180005r37","doi-asserted-by":"publisher","first-page":"302","DOI":"10.1378\/chest.122.1.302","article-title":"Fungal endocarditis, 1995-2000.","volume":"122","author":"Pierrotti","year":"2002","journal-title":"Chest"},{"issue":"1","key":"jrv180005r38","doi-asserted-by":"publisher","first-page":"177","DOI":"10.1128\/CMR.14.1.177-207.2001","article-title":"Endocarditis due to rare and fastidious bacteria.","volume":"14","author":"Brouqui","year":"2001","journal-title":"Clin Microbiol Rev"},{"issue":"2","key":"jrv180005r39","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1086\/652976","article-title":"Comprehensive diagnostic strategy for blood culture-negative endocarditis: a prospective study of 819 new cases.","volume":"51","author":"Fournier","year":"2010","journal-title":"Clin Infect Dis"},{"issue":"1-2","key":"jrv180005r40","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.medmal.2014.11.003","article-title":"Update on blood culture-negative endocarditis.","volume":"45","author":"Tattevin","year":"2015","journal-title":"Med Mal Infect"},{"issue":"44","key":"jrv180005r41","doi-asserted-by":"publisher","first-page":"3075","DOI":"10.1093\/eurheartj\/ehv319","article-title":"2015 ESC Guidelines for the management of infective endocarditis: the Task Force for the Management of Infective Endocarditis of the European Society of Cardiology (ESC).","volume":"36","author":"Habib","year":"2015","journal-title":"Eur Heart J"},{"issue":"4","key":"jrv180005r42","doi-asserted-by":"publisher","first-page":"315","DOI":"10.1016\/j.echo.2015.12.009","article-title":"An approach to improve the negative predictive value and clinical utility of transthoracic echocardiography in suspected native valve infective endocarditis.","volume":"29","author":"Sivak","year":"2016","journal-title":"J Am Soc Echocardiogr"},{"issue":"2","key":"jrv180005r43","doi-asserted-by":"publisher","first-page":"391","DOI":"10.1016\/0735-1097(91)90591-V","article-title":"Diagnostic value of transesophageal compared with transthoracic echocardiography in infective endocarditis.","volume":"18","author":"Shively","year":"1991","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"jrv180005r44","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1093\/ejechocard\/jeq004","article-title":"Recommendations for the practice of echocardiography in infective endocarditis.","volume":"11","author":"Habib","year":"2010","journal-title":"Eur J Echocardiogr"},{"issue":"5","key":"jrv180005r45","doi-asserted-by":"publisher","first-page":"436","DOI":"10.1016\/j.jacc.2008.01.077","article-title":"Multislice computed tomography in infective endocarditis: comparison with transesophageal echocardiography and intraoperative findings.","volume":"53","author":"Feuchtner","year":"2009","journal-title":"J Am Coll Cardiol"},{"issue":"22","key":"jrv180005r46","doi-asserted-by":"publisher","first-page":"2438","DOI":"10.1016\/j.jacc.2014.02.537","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: executive summary: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"3","key":"jrv180005r47","doi-asserted-by":"publisher","first-page":"e006986","DOI":"10.1161\/CIRCIMAGING.117.006986","article-title":"Comparison of cardiac computed tomography with transesophageal echocardiography for identifying vegetation and intracardiac complications in patients with infective endocarditis in the era of 3-dimensional images.","volume":"11","author":"Kim","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"3","key":"jrv180005r48","doi-asserted-by":"publisher","first-page":"e007626","DOI":"10.1161\/CIRCIMAGING.118.007626","article-title":"Beyond standard echocardiography in infective endocarditis: computed tomography, 3-dimensional imaging, and multi-imaging.","volume":"11","author":"Salaun","year":"2018","journal-title":"Circ Cardiovasc Imaging"},{"issue":"23","key":"jrv180005r49","doi-asserted-by":"publisher","first-page":"2374","DOI":"10.1016\/j.jacc.2013.01.092","article-title":"Positron emission tomography\/computed tomography for diagnosis of prosthetic valve endocarditis: increased valvular 18F-fluorodeoxyglucose uptake as a novel major criterion.","volume":"61","author":"Saby","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"jrv180005r50","doi-asserted-by":"publisher","first-page":"1435","DOI":"10.1161\/CIR.0000000000000296","article-title":"Infective endocarditis in adults: diagnosis, antimicrobial therapy, and management of complications: a scientific statement for healthcare professionals from the American Heart Association.","volume":"132","author":"Baddour","year":"2015","journal-title":"Circulation"},{"issue":"5","key":"jrv180005r51","doi-asserted-by":"publisher","first-page":"333","DOI":"10.1097\/01.md.0000091184.93122.09","article-title":"Staphylococcus aureus bacteremia: recurrence and the impact of antibiotic treatment in a prospective multicenter study.","volume":"82","author":"Chang","year":"2003","journal-title":"Medicine (Baltimore)"},{"issue":"7","key":"jrv180005r52","doi-asserted-by":"publisher","first-page":"653","DOI":"10.1056\/NEJMoa053783","article-title":"Daptomycin versus standard therapy for bacteremia and endocarditis caused by Staphylococcus aureus.","volume":"355","author":"Fowler","year":"2006","journal-title":"N Engl J Med"},{"issue":"3","key":"jrv180005r53","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1093\/cid\/cir034","article-title":"Clinical practice guidelines by the infectious diseases society of America for the treatment of methicillin-resistant Staphylococcus aureus infections in adults and children.","volume":"52","author":"Liu","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"4","key":"jrv180005r54","doi-asserted-by":"publisher","first-page":"480","DOI":"10.1001\/archinte.1976.03630040082017","article-title":"Combination antibiotic therapy in staphylococcal endocarditis: the use of methicillin sodium-gentamicin sulfate therapy.","volume":"136","author":"Murray","year":"1976","journal-title":"Arch Intern Med"},{"issue":"6","key":"jrv180005r55","doi-asserted-by":"publisher","first-page":"713","DOI":"10.1086\/598174","article-title":"Initial low-dose gentamicin for Staphylococcus aureus bacteremia and endocarditis is nephrotoxic.","volume":"48","author":"Cosgrove","year":"2009","journal-title":"Clin Infect Dis"},{"issue":"9","key":"jrv180005r56","doi-asserted-by":"publisher","first-page":"674","DOI":"10.7326\/0003-4819-115-9-674","article-title":"Slow response to vancomycin or vancomycin plus rifampin in methicillin-resistant Staphylococcus aureus endocarditis.","volume":"115","author":"Levine","year":"1991","journal-title":"Ann Intern Med"},{"issue":"7","key":"jrv180005r57","doi-asserted-by":"publisher","first-page":"2463","DOI":"10.1128\/AAC.00300-08","article-title":"Addition of rifampin to standard therapy for treatment of native valve infective endocarditis caused by Staphylococcus aureus.","volume":"52","author":"Riedel","year":"2008","journal-title":"Antimicrob Agents Chemother"},{"issue":"3","key":"jrv180005r58","doi-asserted-by":"publisher","first-page":"340","DOI":"10.1093\/infdis\/jir270","article-title":"Antibiotic choice may not explain poorer outcomes in patients with Staphylococcus aureus bacteremia and high vancomycin minimum inhibitory concentrations.","volume":"204","author":"Holmes","year":"2011","journal-title":"J Infect Dis"},{"issue":"6","key":"jrv180005r59","doi-asserted-by":"publisher","first-page":"755","DOI":"10.1093\/cid\/cir935","article-title":"The clinical significance of vancomycin minimum inhibitory concentration in Staphylococcus aureus infections: a systematic review and meta-analysis.","volume":"54","author":"van Hal","year":"2012","journal-title":"Clin Infect Dis"},{"issue":"12","key":"jrv180005r60","doi-asserted-by":"publisher","first-page":"1668","DOI":"10.1093\/cid\/ciu183","article-title":"Effect of vancomycin minimal inhibitory concentration on the outcome of methicillin-susceptible Staphylococcus aureus endocarditis.","volume":"58","author":"Cervera","year":"2014","journal-title":"Clin Infect Dis"},{"issue":"12","key":"jrv180005r61","doi-asserted-by":"publisher","first-page":"5376","DOI":"10.1128\/AAC.00857-10","article-title":"Successful treatment of vancomycin-intermediate Staphylococcus aureus pacemaker lead infective endocarditis with telavancin.","volume":"54","author":"Marcos","year":"2010","journal-title":"Antimicrob Agents Chemother"},{"issue":"2","key":"jrv180005r62","doi-asserted-by":"publisher","first-page":"173","DOI":"10.1093\/cid\/civ808","article-title":"Combination of vancomycin and beta-lactam therapy for methicillin-resistant Staphylococcus aureus bacteremia: a pilot multicenter randomized controlled trial.","volume":"62","author":"Davis","year":"2016","journal-title":"Clin Infect Dis"},{"issue":"2","key":"jrv180005r63","doi-asserted-by":"publisher","first-page":"158","DOI":"10.1093\/cid\/cir340","article-title":"Use of antistaphylococcal beta-lactams to increase daptomycin activity in eradicating persistent bacteremia due to methicillin-resistant Staphylococcus aureus: role of enhanced daptomycin binding.","volume":"53","author":"Dhand","year":"2011","journal-title":"Clin Infect Dis"},{"issue":"7","key":"jrv180005r64","doi-asserted-by":"publisher","first-page":"3976","DOI":"10.1128\/AAC.00589-16","article-title":"Daptomycin-beta-Lactam combinations in a rabbit model of daptomycin-nonsusceptible methicillin-resistant Staphylococcus aureus endocarditis.","volume":"60","author":"Chambers","year":"2016","journal-title":"Antimicrob Agents Chemother"},{"issue":"10","key":"jrv180005r65","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.1016\/j.clinthera.2014.05.061","article-title":"Antimicrobial salvage therapy for persistent staphylococcal bacteremia using daptomycin plus ceftaroline.","volume":"36","author":"Sakoulas","year":"2014","journal-title":"Clin Ther"},{"issue":"5","key":"jrv180005r66","doi-asserted-by":"publisher","first-page":"1267","DOI":"10.1093\/jac\/dks006","article-title":"Methicillin-resistant Staphylococcus aureus bacteraemia and endocarditis treated with ceftaroline salvage therapy.","volume":"67","author":"Ho","year":"2012","journal-title":"J Antimicrob Chemother"},{"issue":"1","key":"jrv180005r67","doi-asserted-by":"publisher","first-page":"42","DOI":"10.1007\/s10156-012-0449-9","article-title":"The use of ceftaroline fosamil in methicillin-resistant Staphylococcus aureus endocarditis and deep-seated MRSA infections: a retrospective case series of 10 patients.","volume":"19","author":"Lin","year":"2013","journal-title":"J Infect Chemother"},{"issue":"6","key":"jrv180005r68","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/j.jinf.2012.08.007","article-title":"Efficacy of linezolid-based salvage therapy compared with glycopeptide-based therapy in patients with persistent methicillin-resistant Staphylococcus aureus bacteremia.","volume":"65","author":"Park","year":"2012","journal-title":"J Infect"},{"issue":"6","key":"jrv180005r69","doi-asserted-by":"publisher","first-page":"379","DOI":"10.3109\/00365548.2014.995696","article-title":"Telavancin for refractory methicillin-resistant Staphylococcus aureus bacteremia and infective endocarditis.","volume":"47","author":"Ruggero","year":"2015","journal-title":"Infect Dis (Lond)"},{"issue":"7","key":"jrv180005r70","doi-asserted-by":"publisher","first-page":"759","DOI":"10.1016\/j.amjmed.2005.02.020","article-title":"Enterococcal endocarditis: 107 cases from the international collaboration on endocarditis merged database.","volume":"118","author":"McDonald","year":"2005","journal-title":"Am J Med"},{"issue":"9","key":"jrv180005r71","doi-asserted-by":"publisher","first-page":"1261","DOI":"10.1093\/cid\/cit052","article-title":"Ampicillin plus ceftriaxone is as effective as ampicillin plus gentamicin for treating Enterococcus faecalis infective endocarditis.","volume":"56","author":"Fernandez-Hidalgo","year":"2013","journal-title":"Clin Infect Dis"},{"issue":"12","key":"jrv180005r72","doi-asserted-by":"publisher","first-page":"1140","DOI":"10.1111\/1469-0691.12166","article-title":"Enterococcal endocarditis in the beginning of the 21st century: analysis from the International Collaboration on Endocarditis-Prospective Cohort Study.","volume":"19","author":"Chirouze","year":"2013","journal-title":"Clin Microbiol Infect"},{"issue":"8","key":"jrv180005r73","doi-asserted-by":"publisher","first-page":"574","DOI":"10.7326\/0003-4819-146-8-200704170-00008","article-title":"Brief communication: treatment of Enterococcus faecalis endocarditis with ampicillin plus ceftriaxone.","volume":"146","author":"Gavalda","year":"2007","journal-title":"Ann Intern Med"},{"issue":"17","key":"jrv180005r74","doi-asserted-by":"publisher","first-page":"1763","DOI":"10.1161\/CIRCULATIONAHA.113.002431","article-title":"A new era for treating Enterococcus faecalis endocarditis: ampicillin plus short-course gentamicin or ampicillin plus ceftriaxone: that is the question!","volume":"127","author":"Miro","year":"2013","journal-title":"Circulation"},{"issue":"12","key":"jrv180005r75","doi-asserted-by":"publisher","first-page":"O1075","DOI":"10.1111\/1469-0691.12756","article-title":"Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone.","volume":"20","author":"Pericas","year":"2014","journal-title":"Clin Microbiol Infect"},{"issue":"23","key":"jrv180005r76","doi-asserted-by":"publisher","first-page":"e394","DOI":"10.1161\/CIRCULATIONAHA.105.165564","article-title":"Infective endocarditis: diagnosis, antimicrobial therapy, and management of complications: a statement for healthcare professionals from the Committee on Rheumatic Fever, Endocarditis, and Kawasaki Disease, Council on Cardiovascular Disease in the Young, and the Councils on Clinical Cardiology, Stroke, and Cardiovascular Surgery and Anesthesia, American Heart Association: endorsed by the Infectious Diseases Society of America.","volume":"111","author":"Baddour","year":"2005","journal-title":"Circulation"},{"issue":"5","key":"jrv180005r77","doi-asserted-by":"publisher","first-page":"615","DOI":"10.1086\/cid.2003.36.issue-5","article-title":"Combination antibiotic therapy for infective endocarditis.","volume":"36","author":"Le","year":"2003","journal-title":"Clin Infect Dis"},{"issue":"3","key":"jrv180005r78","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1016\/j.jhin.2009.12.007","article-title":"Trends in antimicrobial resistance of clinical isolates of Enterococcus faecalis and Enterococcus faecium in Greece between 2002 and 2007.","volume":"75","author":"Protonotariou","year":"2010","journal-title":"J Hosp Infect"},{"issue":"20","key":"jrv180005r79","doi-asserted-by":"publisher","first-page":"2239","DOI":"10.1001\/jama.2011.1701","article-title":"Association between valvular surgery and mortality among patients with infective endocarditis complicated by heart failure.","volume":"306","author":"Kiefer","year":"2011","journal-title":"JAMA"},{"issue":"22","key":"jrv180005r80","doi-asserted-by":"publisher","first-page":"e57","DOI":"10.1016\/j.jacc.2014.02.536","article-title":"2014 AHA\/ACC guideline for the management of patients with valvular heart disease: a report of the American College of Cardiology\/American Heart Association Task Force on Practice Guidelines.","volume":"63","author":"Nishimura","year":"2014","journal-title":"J Am Coll Cardiol"},{"issue":"15","key":"jrv180005r81","doi-asserted-by":"publisher","first-page":"1384","DOI":"10.1016\/j.jacc.2013.07.029","article-title":"Prediction of symptomatic embolism in infective endocarditis: construction and validation of a risk calculator in a multicenter cohort.","volume":"62","author":"Hubert","year":"2013","journal-title":"J Am Coll Cardiol"},{"issue":"5","key":"jrv180005r82","doi-asserted-by":"publisher","first-page":"741","DOI":"10.1093\/cid\/ciu871","article-title":"Impact of early valve surgery on outcome of Staphylococcus aureus prosthetic valve infective endocarditis: analysis in the International Collaboration of Endocarditis-Prospective Cohort Study.","volume":"60","author":"Chirouze","year":"2015","journal-title":"Clin Infect Dis"},{"issue":"2","key":"jrv180005r83","doi-asserted-by":"publisher","first-page":"147","DOI":"10.1016\/j.amjmed.2005.09.037","article-title":"Medical versus surgical management of Staphylococcus aureus prosthetic valve endocarditis.","volume":"119","author":"Sohail","year":"2006","journal-title":"Am J Med"},{"issue":"8","key":"jrv180005r84","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.amjcard.2007.12.015","article-title":"Management of prosthetic valve infective endocarditis.","volume":"101","author":"Hill","year":"2008","journal-title":"Am J Cardiol"},{"issue":"3","key":"jrv180005r85","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1016\/j.jinf.2004.10.016","article-title":"A meta-analysis of medical versus surgical therapy for Candida endocarditis.","volume":"51","author":"Steinbach","year":"2005","journal-title":"J Infect"},{"issue":"4","key":"jrv180005r86","doi-asserted-by":"publisher","first-page":"2365","DOI":"10.1128\/AAC.04867-14","article-title":"Candida infective endocarditis: an observational cohort study with a focus on therapy.","volume":"59","author":"Arnold","year":"2015","journal-title":"Antimicrob Agents Chemother"},{"issue":"6","key":"jrv180005r87","doi-asserted-by":"publisher","first-page":"825","DOI":"10.1093\/cid\/cix913","article-title":"Prosthetic valve Candida spp endocarditis: new insights into long-term prognosis\u2014the ESCAPE Study.","volume":"66","author":"Rivoisy","year":"2018","journal-title":"Clin Infect Dis"},{"issue":"4","key":"jrv180005r88","doi-asserted-by":"publisher","first-page":"E99","DOI":"10.1111\/j.1469-0691.2012.03764.x","article-title":"Diagnosis, management and outcome of Candida endocarditis.","volume":"18","author":"Lefort","year":"2012","journal-title":"Clin Microbiol Infect"},{"issue":"4","key":"jrv180005r89","doi-asserted-by":"publisher","first-page":"290","DOI":"10.1016\/j.ijantimicag.2014.07.003","article-title":"Fungal endocarditis: current challenges.","volume":"44","author":"Tattevin","year":"2014","journal-title":"Int J Antimicrob Agents"},{"issue":"12","key":"jrv180005r90","doi-asserted-by":"publisher","first-page":"e1040","DOI":"10.1016\/j.ijid.2010.08.005","article-title":"Aspergillus endocarditis: a review of the literature.","volume":"14","author":"Kalokhe","year":"2010","journal-title":"Int J Infect Dis"},{"issue":"3","key":"jrv180005r91","doi-asserted-by":"publisher","first-page":"875","DOI":"10.1016\/j.athoracsur.2015.03.019","article-title":"Injection drug use and outcomes after surgical intervention for infective endocarditis.","volume":"100","author":"Shrestha","year":"2015","journal-title":"Ann Thorac Surg"},{"issue":"1","key":"jrv180005r92","doi-asserted-by":"publisher","first-page":"51","DOI":"10.1016\/j.athoracsur.2011.08.016","article-title":"Long-term outcome for the surgical treatment of infective endocarditis with a focus on intravenous drug users.","volume":"93","author":"Rabkin","year":"2012","journal-title":"Ann Thorac Surg"},{"issue":"5","key":"jrv180005r93","doi-asserted-by":"publisher","first-page":"633","DOI":"10.1093\/icvts\/ivv397","article-title":"Cardiac surgery for infective endocarditis in patients with intravenous drug use.","volume":"22","author":"Osterdal","year":"2016","journal-title":"Interact Cardiovasc Thorac Surg"},{"issue":"24","key":"jrv180005r94","doi-asserted-by":"publisher","first-page":"3118","DOI":"10.1161\/CIRCULATIONAHA.107.758524","article-title":"Bacteremia associated with toothbrushing and dental extraction.","volume":"117","author":"Lockhart","year":"2008","journal-title":"Circulation"},{"issue":"5","key":"jrv180005r95","doi-asserted-by":"publisher","first-page":"317","DOI":"10.1007\/s002469900477","article-title":"Dentists are innocent! \u201cEveryday\u201d bacteremia is the real culprit: a review and assessment of the evidence that dental surgical procedures are a principal cause of bacterial endocarditis in children.","volume":"20","author":"Roberts","year":"1999","journal-title":"Pediatr Cardiol"},{"issue":"10","key":"jrv180005r96","first-page":"CD003813","article-title":"Antibiotics for the prophylaxis of bacterial endocarditis in dentistry.","author":"Glenny","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"7","key":"jrv180005r97","doi-asserted-by":"publisher","first-page":"874","DOI":"10.1016\/j.mayocp.2015.04.019","article-title":"Incidence of infective endocarditis due to viridans group streptococci before and after the 2007 American Heart Association\u2019s prevention guidelines: an extended evaluation of the Olmsted County, Minnesota, population and nationwide inpatient sample.","volume":"90","author":"DeSimone","year":"2015","journal-title":"Mayo Clin Proc"},{"issue":"8","key":"jrv180005r98","doi-asserted-by":"publisher","first-page":"2382","DOI":"10.1093\/jac\/dkv115","article-title":"Incidence and nature of adverse reactions to antibiotics used as endocarditis prophylaxis.","volume":"70","author":"Thornhill","year":"2015","journal-title":"J Antimicrob Chemother"},{"issue":"12","key":"jrv180005r99","doi-asserted-by":"publisher","first-page":"1678","DOI":"10.1093\/cid\/cix237","article-title":"Oral streptococcal endocarditis, oral hygiene habits, and recent dental procedures: a case-control study.","volume":"64","author":"Duval","year":"2017","journal-title":"Clin Infect Dis"},{"issue":"15","key":"jrv180005r100","doi-asserted-by":"publisher","first-page":"1736","DOI":"10.1161\/CIRCULATIONAHA.106.183095","article-title":"Prevention of infective endocarditis: guidelines from the American Heart Association: a guideline from the American Heart Association Rheumatic Fever, Endocarditis, and Kawasaki Disease Committee, Council on Cardiovascular Disease in the Young, and the Council on Clinical Cardiology, Council on Cardiovascular Surgery and Anesthesia, and the Quality of Care and Outcomes Research Interdisciplinary Working Group.","volume":"116","author":"Wilson","year":"2007","journal-title":"Circulation"},{"issue":"19","key":"jrv180005r101","doi-asserted-by":"publisher","first-page":"2369","DOI":"10.1093\/eurheartj\/ehp285","article-title":"Guidelines on the prevention, diagnosis, and treatment of infective endocarditis (new version 2009): the Task Force on the Prevention, Diagnosis, and Treatment of Infective Endocarditis of the European Society of Cardiology (ESC). Endorsed by the European Society of Clinical Microbiology and Infectious Diseases (ESCMID) and the International Society of Chemotherapy (ISC) for Infection and Cancer.","volume":"30","author":"Habib","year":"2009","journal-title":"Eur Heart J"},{"issue":"9974","key":"jrv180005r103","doi-asserted-by":"publisher","first-page":"1219","DOI":"10.1016\/S0140-6736(14)62007-9","article-title":"Incidence of infective endocarditis in England, 2000-13: a secular trend, interrupted time-series analysis.","volume":"385","author":"Dayer","year":"2015","journal-title":"Lancet"},{"issue":"17","key":"jrv180005r104","doi-asserted-by":"publisher","first-page":"1597","DOI":"10.1056\/NEJMoa1008232","article-title":"Transcatheter aortic-valve implantation for aortic stenosis in patients who cannot undergo surgery.","volume":"363","author":"Leon","year":"2010","journal-title":"N Engl J Med"},{"issue":"2","key":"jrv180005r105","doi-asserted-by":"publisher","first-page":"334","DOI":"10.1016\/j.jcin.2014.09.013","article-title":"Prosthetic valve endocarditis after transcatheter valve replacement: a systematic review.","volume":"8","author":"Amat-Santos","year":"2015","journal-title":"JACC Cardiovasc Interv"},{"issue":"3","key":"jrv180005r106","doi-asserted-by":"publisher","first-page":"S11","DOI":"10.1016\/j.jtcvs.2012.11.051","article-title":"A comprehensive review of the PARTNER trial.","volume":"145","author":"Svensson","year":"2013","journal-title":"J Thorac Cardiovasc Surg"},{"issue":"3","key":"jrv180005r107","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1161\/CIRCULATIONAHA.117.028783","article-title":"Prosthetic valve endocarditis after surgical aortic valve replacement.","volume":"136","author":"Glaser","year":"2017","journal-title":"Circulation"},{"issue":"12","key":"jrv180005r108","doi-asserted-by":"publisher","first-page":"1354","DOI":"10.1001\/jama.297.12.1354","article-title":"Contemporary clinical profile and outcome of prosthetic valve endocarditis.","volume":"297","author":"Wang","year":"2007","journal-title":"JAMA"},{"issue":"10","key":"jrv180005r109","doi-asserted-by":"publisher","first-page":"1083","DOI":"10.1001\/jama.2016.12347","article-title":"Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death.","volume":"316","author":"Regueiro","year":"2016","journal-title":"JAMA"},{"issue":"16","key":"jrv180005r110","doi-asserted-by":"publisher","first-page":"1495","DOI":"10.1001\/jamainternmed.2013.8203","article-title":"In-hospital and 1-year mortality in patients undergoing early surgery for prosthetic valve endocarditis.","volume":"173","author":"Lalani","year":"2013","journal-title":"JAMA Intern Med"},{"issue":"10","key":"jrv180005r111","doi-asserted-by":"publisher","first-page":"1075","DOI":"10.1016\/j.jcmg.2013.08.001","article-title":"Radiolabeled WBC scintigraphy in the diagnostic workup of patients with suspected device-related infections.","volume":"6","author":"Erba","year":"2013","journal-title":"JACC Cardiovasc Imaging"},{"issue":"3","key":"jrv180005r112","doi-asserted-by":"publisher","first-page":"458","DOI":"10.1161\/CIRCULATIONAHA.109.192665","article-title":"Update on cardiovascular implantable electronic device infections and their management: a scientific statement from the American Heart Association.","volume":"121","author":"Baddour","year":"2010","journal-title":"Circulation"},{"issue":"2","key":"jrv180005r113","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1161\/CIRCEP.111.965277","article-title":"Long-term mortality after transvenous lead extraction.","volume":"5","author":"Maytin","year":"2012","journal-title":"Circ Arrhythm Electrophysiol"},{"issue":"4","key":"jrv180005r114","doi-asserted-by":"publisher","first-page":"e003016","DOI":"10.1161\/JAHA.115.003016","article-title":"Validated risk score for predicting 6-month mortality in infective endocarditis.","volume":"5","author":"Park","year":"2016","journal-title":"J Am Heart Assoc"},{"issue":"1","key":"jrv180005r115","doi-asserted-by":"publisher","first-page":"61","DOI":"10.1136\/heart.88.1.61","article-title":"Infective endocarditis: determinants of long term outcome.","volume":"88","author":"Netzer","year":"2002","journal-title":"Heart"},{"issue":"2","key":"jrv180005r116","doi-asserted-by":"publisher","first-page":"131","DOI":"10.1161\/CIRCULATIONAHA.114.012461","article-title":"Association between surgical indications, operative risk, and clinical outcome in infective endocarditis: a prospective study from the International Collaboration on Endocarditis.","volume":"131","author":"Chu","year":"2015","journal-title":"Circulation"},{"issue":"19","key":"jrv180005r117","doi-asserted-by":"publisher","first-page":"1684","DOI":"10.1161\/CIRCULATIONAHA.114.012717","article-title":"Long-term clinical outcome of major adverse cardiac events in survivors of infective endocarditis: a nationwide population-based study.","volume":"130","author":"Shih","year":"2014","journal-title":"Circulation"},{"key":"jrv180005r102","unstructured":"Prophylaxis against infective endocarditis: antimicrobial prophylaxis against infective endocarditis in adults and children undergoing interventional procedures (CG64). National Institute for Health and Care Excellence (NICE). http:\/\/www.nice.org.uk\/guidance\/CG64. Accessed April 26, 2018."}],"container-title":["JAMA"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/jamanetwork.com\/journals\/jama\/fullarticle\/2686799","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2018,7,3]],"date-time":"2018-07-03T15:32:55Z","timestamp":1530631975000},"score":1,"resource":{"primary":{"URL":"http:\/\/jama.jamanetwork.com\/article.aspx?doi=10.1001\/jama.2018.7596"}},"subtitle":["A Review"],"short-title":[],"issued":{"date-parts":[[2018,7,3]]},"references-count":117,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2018,7,3]]}},"URL":"https:\/\/doi.org\/10.1001\/jama.2018.7596","relation":{},"ISSN":["0098-7484"],"issn-type":[{"value":"0098-7484","type":"print"}],"subject":[],"published":{"date-parts":[[2018,7,3]]}}}